Tibet Cheezheng Tibetan Medicine Co Ltd Net Asset Quality Index

Latest as of March 2026: 76.4%

Tibet Cheezheng Tibetan Medicine Co Ltd net asset quality index. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Net Asset Quality Index of 76.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.66 Billion minus total liabilities of CN¥1.57 Billion yields net assets of CN¥5.09 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 002287 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Quality Index

76.4%
Equity / Total Assets

Net Assets

CN¥5.09 Billion
CNY

Total Assets

CN¥6.66 Billion
CNY

Total Liabilities

CN¥1.57 Billion
CNY

Net Asset Quality Index of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)

Net asset quality index of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. This chart shows how Tibet Cheezheng Tibetan Medicine Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 76.4%, representing net assets of CN¥5.09 Billion against total assets of CN¥6.66 Billion CNY. See Tibet Cheezheng Tibetan Medicine Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Tibet Cheezheng Tibetan Medicine Co Ltd Net Asset Quality Index by Year (2006–2025)

Tibet Cheezheng Tibetan Medicine Co Ltd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Tibet Cheezheng Tibetan Medicine Co Ltd worth.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 72.2% CN¥5.00 Billion CN¥6.92 Billion CN¥1.92 Billion ▲ +11.7 pp
2024 60.6% CN¥4.11 Billion CN¥6.79 Billion CN¥2.68 Billion ▲ +0.7 pp
2023 59.9% CN¥3.77 Billion CN¥6.30 Billion CN¥2.53 Billion ▲ +2.3 pp
2022 57.5% CN¥3.39 Billion CN¥5.89 Billion CN¥2.50 Billion ▼ -0.3 pp
2021 57.8% CN¥3.22 Billion CN¥5.57 Billion CN¥2.35 Billion ▼ -1.2 pp
2020 59.1% CN¥2.63 Billion CN¥4.46 Billion CN¥1.82 Billion ▼ -16.7 pp
2019 75.8% CN¥2.26 Billion CN¥2.98 Billion CN¥722.20 Million ▼ -12.6 pp
2018 88.4% CN¥2.05 Billion CN¥2.31 Billion CN¥267.54 Million ▲ +6.0 pp
2017 82.5% CN¥1.89 Billion CN¥2.30 Billion CN¥402.78 Million ▼ -1.9 pp
2016 84.4% CN¥1.75 Billion CN¥2.08 Billion CN¥324.33 Million ▲ +4.6 pp
2015 79.8% CN¥1.65 Billion CN¥2.07 Billion CN¥419.05 Million ▼ -6.7 pp
2014 86.5% CN¥1.55 Billion CN¥1.79 Billion CN¥242.20 Million ▼ -7.9 pp
2013 94.4% CN¥1.45 Billion CN¥1.53 Billion CN¥86.34 Million ▲ +0.0 pp
2012 94.4% CN¥1.35 Billion CN¥1.43 Billion CN¥80.90 Million ▲ +0.2 pp
2011 94.1% CN¥1.28 Billion CN¥1.36 Billion CN¥80.01 Million ▲ +2.5 pp
2010 91.6% CN¥1.21 Billion CN¥1.32 Billion CN¥110.72 Million ▲ +3.4 pp
2009 88.2% CN¥1.14 Billion CN¥1.30 Billion CN¥152.68 Million ▲ +3.9 pp
2008 84.3% CN¥532.28 Million CN¥631.30 Million CN¥99.02 Million ▲ +7.3 pp
2007 77.0% CN¥396.33 Million CN¥514.70 Million CN¥118.37 Million ▼ -0.3 pp
2006 77.3% CN¥456.61 Million CN¥590.98 Million CN¥134.37 Million —
pp = percentage points